Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Sedigheh Amini-Kafiabad"'
Autor:
Fateme Roshanzamir, Sedigheh Amini-Kafiabad, Mahin Nikougoftar Zarif, Ali Arabkhazaeli, Mahshid Mohammadipour
Publikováno v:
European Journal of Translational Myology (2022)
By harmonizing the pre-preparation conditions and also removing some donors’ variations, the current study took one step forward to investigate whether different leukocyte filtration sets influence the quality of RBCs throughout the storage time. T
Externí odkaz:
https://doaj.org/article/6da1a484e8874e2b9bba90a80d1347ab
Publikováno v:
Current Drug Delivery. 20:261-280
Purpose: To obtain safe and qualified blood products (e.g., platelets, plasma, and red blood cells), various limitations such as limited shelf life (especially for platelets) and stability must be addressed. In this review study, the most commonly us
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23322672e3a1fe18db2e63a87be564ce
https://doi.org/10.2174/1567201819666220513092020
https://doi.org/10.2174/1567201819666220513092020
Publikováno v:
Current Nanoscience. 18:304-318
Background: Platelets are sensitive to chilling, so the optimal storage temperature for maintaining normal function and structure in platelets is 22-24 °C up to 3-5 days. Introduction: Platelets are important blood cells involved in immunity, inflam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c15fb1b426417d9575745a5e7e654e1d
https://doi.org/10.2174/1566524021666210708154736
https://doi.org/10.2174/1566524021666210708154736
Publikováno v:
Blood research
Maintaining the quality of platelet products and increasing their storage time are priorities for treatment applications. The formation of platelet storage lesions that limit the storage period and preservation temperature, which can prepare a decent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce9f402a05aadba675f2306965907f90
http://europepmc.org/articles/PMC8721452
http://europepmc.org/articles/PMC8721452
Publikováno v:
Transfusion Medicine. 32:64-70
OBJECTIVE The current study analysed the viral safety among Iranian blood donors. BACKGROUND Plasma products demand is increasing in the world. With contract plasma fractionation, the plasma wastage decreases and the access of patients to plasma-deri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e520209c634266b8db5361f910886215
https://doi.org/10.1111/tme.12833
https://doi.org/10.1111/tme.12833
Publikováno v:
Journal of Pharmacy and Pharmacology. 74:179-190
Objectives Nanotechnology and nanoparticles are used in different applications in disease monitoring and therapy in contact with blood. Nanoparticles showed different effects on blood components and reduced or improved the function of therapeutic pla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcb7f0c8046cdab768c583cb92b35a6e
https://doi.org/10.1093/jpp/rgab089
https://doi.org/10.1093/jpp/rgab089
Autor:
Fahimeh Ranjbar Kermani, Ali Arabkhazaeli, Peyman Eshghi, Mahtab Maghsudlu, Sedigheh Amini-Kafiabad, Amir Teimourpour, Mahmoud Reza Pourkarim
Publikováno v:
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.
OBJECTIVES: Iran is one of the countries that have been confronted with the SARS-CoV-2 epidemic since February 2020. This study aimed to determine the levels of specific IgG antibodies against SARS-CoV-2 among healthy blood donors to estimate the bur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c2232ff48af1027b7d82c1038a51dc7
https://pubmed.ncbi.nlm.nih.gov/36084918
https://pubmed.ncbi.nlm.nih.gov/36084918
Autor:
Zohreh Sharifi, Mohammad Ali Mansournia, Mahtab Maghsudlu, Fahimeh Ranjbar Kermani, Sedigheh Amini-Kafiabad, Kamran Mousavi Hosseini
Publikováno v:
Hepatitis Monthly. 20
Background: Hepatitis C virus (HCV) is a major cause of liver diseases. Transmission of HCV, as a blood-borne virus, is a major concern for the safety of blood products. In Iran, intravenous drug abuse is a major risk factor for HCV transmission. Rec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::36f8ce4370aab3aed2c5878ac2c892bd
https://doi.org/10.5812/hepatmon.108936
https://doi.org/10.5812/hepatmon.108936
Autor:
Sara Riyahi, Mahtab Maghsudlu, Sedigheh Amini-Kafiabad, Daryoush Minai Tehrani, Seyed Moayed Alavian
Publikováno v:
Hepatitis Monthly. 20
Background: Eliminating high-risk individuals has a special role in ensuring blood safety. Due to epidemiological, demographic, and even cultural changes in each country, this process should be continuously evaluated and reviewed, if necessary. Objec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::87f413e61660b943654aa4f90b72f472
https://doi.org/10.5812/hepatmon.109451
https://doi.org/10.5812/hepatmon.109451
Autor:
Zohreh Sharifi, Kamran Mousavi Hosseini, Fahimeh Ranjbar Kermani, Mohammad Ali Mansournia, Mahtab Maghsudlu, Sedigheh Amini-Kafiabad
Publikováno v:
Hepatitis Monthly. 20
Background: With the identification of blood donors with a subsequent positive result in HCV screening and the possibility of HCV transmission via their previous negative donations, the role of look-back investigation has been crucial in enhancing bl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::15f2c01b4522a6a982ab232e1c40071b
https://doi.org/10.5812/hepatmon.108002
https://doi.org/10.5812/hepatmon.108002